| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0005 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |